Biomarin pharmaceutical market cap

Author: rbko

August undefined, 2024

WebFind the latest BioMarin Pharmaceutical Inc. (BMRN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 18.394B: Beta (5Y ... Discover historical prices for BMRN stock on Yahoo Finance. View daily, weekly or … Find the latest BioMarin Pharmaceutical Inc. (BMRN) stock discussion in Yahoo … Interactive Chart for BioMarin Pharmaceutical Inc. (BMRN), analyze all … View the basic BMRN option chain and compare options of BioMarin … See BioMarin Pharmaceutical Inc. (BMRN) stock analyst estimates, including … See the company profile for BioMarin Pharmaceutical Inc. (BMRN) including … Find out the direct holders, institutional holders and mutual fund holders for … Find out all the key statistics for BioMarin Pharmaceutical Inc. (BMRN), including … See BioMarin Pharmaceutical Inc. (BMRN) Environment, Social and Governance … Get the detailed quarterly/annual income statement for BioMarin Pharmaceutical … WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of $70.73 and a twelve month high...

Biomarin Pharmaceutical Stock Price Today (NASDAQ: BMRN) …

WebDec 30, 2024 · Pharma giant Pfizer recently announced that it will acquire Arena Pharmaceuticals for $100 per share or a total equity value of approximately $6.7 billion to further expand its portfolio. Per... WebJan 22, 2024 · Market Cap. $19B. Today's Change (-1.56%) -$1.55. Current Price ... That's why I like BioMarin Pharmaceutical (BMRN-1.56%), a biotech company founded in … sometimes the old ways are best

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought …

WebApr 13, 2024 · The company has a market cap of $18.27 billion, a price-to-earnings ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a twelve month low of … WebApr 13, 2024 · The firm has a market capitalization of $18.27 billion, a PE ratio of 132.38 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. WebApr 10, 2024 · BioMarin Pharmaceutical's mailing address is 770 Lindaro Street, San Rafael CA, 94901. The official website for the company is www.bmrn.com. The biotechnology company can be reached via phone … small company private healthcare

BioMarin Pharmaceutical (BMRN) - Revenue

WebMarket Cap: $17.4B: Shares Short: 7M: Financials See more. Revenue (12 Mos) $2B: Revenue Growth (YoY) 19.5%: ... BioMarin’s stock falls after another company’s dwarfism drug moves into Phase 3 clinical trials. ... 770 Lindaro Street, San Rafael, CA, United States, 94901: Sector: Healthcare: Industry: Biotechnology: Full-Time Employees ... Web26 rows · Mar 22, 2024 · Biomarin Pharmaceutical Market Cap: 17.44B for March 29, 2024. Market Cap Chart. Historical Market Cap Data. View and export this data back to … sometimes there\u0027s just not enough rocksWebApr 10, 2024 · Biomarin Pharmaceutical Inc.'s market capitalization is $18.49 B by 186.53 M shares outstanding. Is Biomarin Pharmaceutical stock a Buy, Sell or Hold? … sometimes there is no next time

"WebBiomarin Pharmaceutical Inc (BMRN) Stock Price & News - Google Finance Home BMRN • NASDAQ Biomarin Pharmaceutical Inc Follow Share $96.60 After Hours: $96.60 (0.00%) 0.00 Closed: Apr 3,... " - Biomarin pharmaceutical market cap

Biomarin pharmaceutical market cap

BMRN - Biomarin Pharmaceutical Inc Stock Price Quote - NASDAQ Mo…

WebCurrent and historical revenue charts for BioMarin Pharmaceutical. As of April 2024 BioMarin Pharmaceutical's TTM revenue is of $2.09 B. companies: 7,323 total market … WebApr 10, 2024 · BMRN Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. …

Did you know?

Web2 days ago · Technical analysis trends BIOMARIN PHARMACEUTICAL INC. Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS Revisions More Estimates Revisions Managers and Directors More about the company Sector and Competitors More Results WebApr 11, 2024 · With Biomarin Pharmaceutical stock trading at $94.30 per share, the total value of Biomarin Pharmaceutical stock (market capitalization) is $17.59B. Biomarin …

WebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research … WebApr 12, 2024 · The stock has a market capitalization of $18.25 billion, a PE ratio of 132.22 and a beta of 0.38. BioMarin Pharmaceutical ( NASDAQ:BMRN – Get Rating) last announced its quarterly earnings...

WebApr 9, 2024 · BioMarin Pharmaceutical Inc. has a 12-month low of $70.73 and a 12-month high of $117.77. The company has a market cap of $18.58 billion, a PE ratio of 134.59 and a beta of 0.38. The stock has a 50 day simple moving average of $100.53 and a 200-day simple moving average of $98.13. WebApr 11, 2024 · The firm has a market capitalization of $18.29 billion, a P/E ratio of 132.50 and a beta of 0.38. BioMarin Pharmaceutical Inc. has a fifty-two week low of $70.73 and a fifty-two week high...

WebApr 6, 2024 · About the company. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and …

WebAccording to BioMarin Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $2.09 B . In 2024 the company made a revenue of $1.84 B a decrease over the years 2024 revenue that were of $1.86 B .The revenue is the total amount of income that a company generates by the sale of goods or services. sometimes thesaurusWeb24 rows · As of March 2024 BioMarin Pharmaceutical has a market cap of $16.71 Billion. This makes BioMarin Pharmaceutical the world's 978th most valuable company by market cap according to our data. The … sometimes the side chick ain\u0027t even a chickWebApr 13, 2024 · The business’s fifty day moving average price is $99.47 and its 200 day moving average price is $98.40. The firm has a market capitalization of $18.27 billion, a … small company sharesWebBioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and ... Market … sometimes there aren\u0027t enough rocksWebGet the latest Biomarin Pharmaceutical Inc (BMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed … small company redundancy processWebApr 12, 2024 · BioMarin Pharmaceutical Inc. has a 12 month low of $70.73 and a 12 month high of $117.77. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.67 and a quick ratio of 3.15. The business has a 50 day simple moving average of $99.85 and a 200-day simple moving average of $98.40. small company reporting booksWebBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California.It has offices and facilities in the United States, South America, … small company share tips